REFSUM DISEASE
DEFINITION:
A disorder of peroxisomes characterized by the accumulation of
phytanic acid resulting in the classic triad of peripheral
neuropathy, retinitis pigmentosa, and cerebellar ataxia.
EPIDEMIOLOGY:
- incidence: rare, over 100 cases reported
- age of onset:
- nightblindness can occur as early as adolescence
- risk factors:
- familial - autosomal recessive
- chrom.#: ?
- gene: phytanoyl-CoA hydroxylase (PhyH)
- M = F
PATHOGENESIS:
- also called Phytanic Acid Storage Disease, Heredopathia
Atactica Polyneuritiformis
- PhyH is a peroxisomal enzyme which catalyzes the first step
in the alpha oxidation of phytanic acid to alpha-hydroxyphytanic
acid
- mutations within the PhyH gene of patients with Refsum
Disease were first identified by G.A. Jansen et al., Nature
Genetics 17(2):190-194 (1997) and include a single nucleotide
deletion, a 111 nucleotide deletion, and a point mutation
2. Pathogenesis
- mutations of PhyH gene -> diminished activity of
phytanoly-CoA hydroxylase -> accumulation of phytanic acid in
the blood and tissues -> neurologic and ophthalmologic
manifestations
CLINICAL FEATURES:
- motor weakness
- muscular atrophy
- absent deep tendon reflexes
- loss of sensation to pain, touch, vibration, temperature
- paresthesias or muscle pain
2. Cerebellar Ataxia
3. Others
- sensorineural hearing loss (in 50% of patients)
- anosmia (in 35%)
- nystagmus (in 25%)
2. Ophthalmologic Manifestations
1. Retinitis Pigmentosa
- nightblindness
- concentric narrowing of the visual fields
- retinal degeneration
- atypical retinal pigmentation
2. Others
- cataracts (in 40%)
- pupillary abnormalities (in 40%)
- miosis
- glaucoma
3. Others
1. Musculoskeletal (in 60%)
- pes cavus
- kyphoscoliosis
- shortening of the metatarsals
- Osteochondritis Dissecans
2. Skin
- ichthyotic changes involving the trunk, palms, and soles
3. Cardiac
4. Respiratory
5. Renal
INVESTIGATIONS:
1. Diagnosis
- PCR identifying mutations within the PhyH gene
- deficiency of PhyH activity in cultured skin fibroblasts
- prenatal
- deficiency of PhyH activity in cultured amniocytes
- elevated levels of phytanic acid in the blood and tissues
(liver, kidneys)
2. Cerebral Spinal Fluid
- elevated protein
- no increase in cells
3. Evoked Potentials
- prolonged somatosensory evoked responses
- abnormal auditory and visual evoked responses
4. EMG
- evidence of muscular denervation
- prolonged nerve conduction velocities
5. ECG
- non-specific ST-T changes in the precordial leads
- conduction defects
- left ventricular hypertrophy
MANAGEMENT:
1. Supportive
- multidisciplinary approach
- Paediatrics, Neurology, Ophthalmology, Cardiology, PT, etc
- genetic counselling
2. Diet
- limiting phytanic acid and its precursor phytol in the diet
- avoid dairy products (butter, milk, cheese), meats of
ruminants (beef, sheep, lamb), seafood, chlorophyll-containing
foods
- frequently moniter plasma phytanate levels
3. Medical
- plasmaphoresis or plasma exchange for acute exacerbations
4. Prognosis
- slowly progressive if left untreated with frequent
exacerbations and remissions with shortened life expectancy
- exacerbations are triggered by viral illnesses and pregnancy
- cardiac and respiratory complications may lead to sudden
death
- positive clinical response to phytanic acid restriction
ADDITIONAL REFERENCES:
1. Rudolph, A.M., Rudolph's Pediatrics (19th Edition). p.
1863-1864, (1991).
|